ID19632A - Turunan-turunan 4-hidroksi-piperidina - Google Patents
Turunan-turunan 4-hidroksi-piperidinaInfo
- Publication number
- ID19632A ID19632A IDP972464A ID972464A ID19632A ID 19632 A ID19632 A ID 19632A ID P972464 A IDP972464 A ID P972464A ID 972464 A ID972464 A ID 972464A ID 19632 A ID19632 A ID 19632A
- Authority
- ID
- Indonesia
- Prior art keywords
- drivings
- piperidine
- hydroxy
- piperidine drivings
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
- C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
- C07D211/48—Oxygen atoms attached in position 4 having an acyclic carbon atom attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Neurosurgery (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP96111660 | 1996-07-19 | ||
| EP97105366 | 1997-04-01 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ID19632A true ID19632A (id) | 1998-07-23 |
Family
ID=26142078
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IDP972464A ID19632A (id) | 1996-07-19 | 1997-07-16 | Turunan-turunan 4-hidroksi-piperidina |
Country Status (34)
| Country | Link |
|---|---|
| US (1) | US5889026A (pt) |
| EP (1) | EP0824098B1 (pt) |
| JP (1) | JP3179050B2 (pt) |
| KR (1) | KR100235804B1 (pt) |
| CN (1) | CN1120154C (pt) |
| AR (2) | AR007898A1 (pt) |
| AT (1) | ATE207899T1 (pt) |
| AU (1) | AU719352B2 (pt) |
| BR (1) | BR9704031A (pt) |
| CA (1) | CA2210044C (pt) |
| CO (1) | CO4900064A1 (pt) |
| CZ (1) | CZ290898B6 (pt) |
| DE (1) | DE69707782T2 (pt) |
| DK (1) | DK0824098T3 (pt) |
| ES (1) | ES2164967T3 (pt) |
| HK (1) | HK1009124A1 (pt) |
| HR (1) | HRP970394A2 (pt) |
| HU (1) | HUP9701194A3 (pt) |
| ID (1) | ID19632A (pt) |
| IL (1) | IL121299A (pt) |
| MA (1) | MA24274A1 (pt) |
| MX (1) | MX9705387A (pt) |
| NO (1) | NO308657B1 (pt) |
| NZ (1) | NZ328330A (pt) |
| PE (1) | PE86398A1 (pt) |
| PL (1) | PL321201A1 (pt) |
| PT (1) | PT824098E (pt) |
| RU (1) | RU2178412C2 (pt) |
| SG (1) | SG60085A1 (pt) |
| TR (1) | TR199700659A2 (pt) |
| TW (1) | TW498067B (pt) |
| UY (1) | UY24625A1 (pt) |
| YU (1) | YU30197A (pt) |
| ZA (1) | ZA976224B (pt) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL125658A0 (en) | 1997-08-18 | 1999-04-11 | Hoffmann La Roche | Ccr-3 receptor antagonists |
| US6339087B1 (en) | 1997-08-18 | 2002-01-15 | Syntex (U.S.A.) Llc | Cyclic amine derivatives-CCR-3 receptor antagonists |
| CZ302486B6 (cs) * | 1998-06-02 | 2011-06-15 | Osi Pharmaceuticals, Inc. | N-6-Substituovaný 7-deazapurin, zpusob jeho prípravy a farmaceutická kompozice s jeho obsahem |
| CO5150201A1 (es) * | 1998-09-07 | 2002-04-29 | Hoffmann La Roche | Derivados de piperidina |
| EP1131290B1 (en) | 1998-11-20 | 2008-02-20 | F. Hoffmann-La Roche Ag | Piperidine ccr-3 receptor antagonists |
| TWI254043B (en) * | 1999-06-08 | 2006-05-01 | Hoffmann La Roche | Ethanesulfonyl-piperidine derivatives having good affinity to N-methyl-D-aspartate (NMDA) receptor |
| US6432985B2 (en) * | 2000-04-25 | 2002-08-13 | Hoffmann-La Roche Inc. | Neuroprotective substituted piperidine compounds with activity as NMDA NR2B subtype selective antagonists |
| US6407235B1 (en) | 2000-08-21 | 2002-06-18 | Hoffmann-La Roche Inc. | Prodrug acid esters of [2-(4-benzyl-3-hydroxy-piperidin-1-yl)-ethansulfonyl]phenol |
| EP1674087A1 (en) | 2000-10-02 | 2006-06-28 | Pfizer Products Inc. | Prophylactic use of n-methyl-d-aspartate (NMDA) antagonists |
| US6680324B2 (en) * | 2000-12-01 | 2004-01-20 | Osi Pharmaceuticals, Inc. | Compounds specific to adenosine A1 receptors and uses thereof |
| AU2002250256B2 (en) * | 2001-03-08 | 2008-04-03 | Emory University | pH-dependent NMDA receptor antagonists |
| ATE408611T1 (de) * | 2001-07-24 | 2008-10-15 | Richter Gedeon Nyrt | Piperidine als nmda-rezeptorantagonisten |
| EP1450811B1 (en) * | 2001-11-30 | 2009-10-21 | OSI Pharmaceuticals, Inc. | Compounds specific to adenosine A1 and A3 receptors and uses thereof |
| EA011809B1 (ru) * | 2001-12-20 | 2009-06-30 | Оси Фармасьютикалз, Инк. | Пиримидиновые соединения, их применение в качестве a-селективных антагонистов и способ их получения |
| US6951884B2 (en) * | 2002-06-12 | 2005-10-04 | Hoffmann-La Roche Inc. | Fluorobenzamides and uses thereof |
| JP4737418B2 (ja) * | 2003-09-25 | 2011-08-03 | 塩野義製薬株式会社 | Ｎｍｄａ受容体拮抗作用を有するピペリジン誘導体 |
| CA2543287A1 (en) * | 2003-10-23 | 2005-05-06 | F.Hoffmann-La Roche Ag | Benzazepine derivatives as mao-b inhibitors |
| HUP0401522A2 (en) * | 2004-07-29 | 2006-04-28 | Richter Gedeon Vegyeszet | New 4-benzylidene-piperidine derivatives, pharmaceutical compositions containing the same and process for their preparation |
| US7485637B2 (en) * | 2005-01-04 | 2009-02-03 | Hoffmann-La Roche Inc. | Benzoyl-tetrahydropiperidine derivatives |
| US8420680B2 (en) | 2007-06-29 | 2013-04-16 | Emory University | NMDA receptor antagonists for neuroprotection |
| US7869022B2 (en) | 2007-07-18 | 2011-01-11 | Asml Netherlands B.V. | Inspection method and apparatus lithographic apparatus, lithographic processing cell, device manufacturing method and distance measuring system |
| KR20110016891A (ko) * | 2008-05-09 | 2011-02-18 | 에모리 유니버시티 | 신경정신 장애의 치료를 위한 ｎｍｄａ 수용체 길항물질 |
| US7874106B2 (en) * | 2009-02-13 | 2011-01-25 | Ykk Corporation Of America | Sill flashing and end dam assembly |
| CN105193802A (zh) * | 2009-10-19 | 2015-12-30 | 阿米库斯治疗学公司 | 用于预防和/或治疗溶酶体贮积失调的新颖组合物 |
| DK2490532T3 (en) * | 2009-10-19 | 2017-02-27 | Amicus Therapeutics Inc | Hitherto UNKNOWN COMPOSITIONS FOR PREVENTION AND / OR TREATMENT OF DEGENERATIVE DISORDERS IN THE CENTRAL Nervous System |
| US10633336B2 (en) | 2014-12-19 | 2020-04-28 | The Broad Institute, Inc. | Dopamine D2 receptor ligands |
| EP3233799B1 (en) | 2014-12-19 | 2021-05-19 | The Broad Institute, Inc. | Dopamine d2 receptor ligands |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1991012005A1 (en) * | 1990-02-06 | 1991-08-22 | Pfizer Inc. | Neuroprotective 3-piperidino-4-hydroxychroman derivatives and analogs |
| FR2672286B1 (fr) * | 1991-01-31 | 1994-11-18 | Synthelabo | Derives de 1-(4-chlorophenyl)-2-[4-(phenylmethyl)piperidin-1-yl]ethanol, leur preparation et leur application en therapeutique. |
| FR2681319B1 (fr) * | 1991-09-12 | 1995-02-17 | Synthelabo | Derives de 1-(phenoxyalkyl)piperidine, leur preparation et leur application en therapeutique. |
| TW281670B (pt) * | 1993-09-02 | 1996-07-21 | Hoffmann La Roche | |
| ATE183184T1 (de) * | 1994-01-31 | 1999-08-15 | Pfizer | Neuroprotektive chroman verbindungen |
| ZA9610745B (en) * | 1995-12-22 | 1997-06-24 | Warner Lambert Co | 4-Subsituted piperidine analogs and their use as subtype selective nmda receptor antagonists |
| ZA9610736B (en) * | 1995-12-22 | 1997-06-27 | Warner Lambert Co | 2-Substituted piperidine analogs and their use as subtypeselective nmda receptor antagonists |
-
1997
- 1997-06-24 TW TW086108797A patent/TW498067B/zh active
- 1997-07-10 AT AT97111742T patent/ATE207899T1/de active
- 1997-07-10 DK DK97111742T patent/DK0824098T3/da active
- 1997-07-10 ES ES97111742T patent/ES2164967T3/es not_active Expired - Lifetime
- 1997-07-10 PT PT97111742T patent/PT824098E/pt unknown
- 1997-07-10 EP EP97111742A patent/EP0824098B1/en not_active Expired - Lifetime
- 1997-07-10 DE DE69707782T patent/DE69707782T2/de not_active Expired - Lifetime
- 1997-07-11 SG SG1997002449A patent/SG60085A1/en unknown
- 1997-07-11 YU YU30197A patent/YU30197A/sh unknown
- 1997-07-14 ZA ZA9706224A patent/ZA976224B/xx unknown
- 1997-07-14 CA CA002210044A patent/CA2210044C/en not_active Expired - Fee Related
- 1997-07-14 PE PE1997000623A patent/PE86398A1/es not_active Application Discontinuation
- 1997-07-14 US US08/891,781 patent/US5889026A/en not_active Expired - Lifetime
- 1997-07-14 HU HU9701194A patent/HUP9701194A3/hu unknown
- 1997-07-14 IL IL12129997A patent/IL121299A/en not_active IP Right Cessation
- 1997-07-14 NZ NZ328330A patent/NZ328330A/en unknown
- 1997-07-16 MX MX9705387A patent/MX9705387A/es unknown
- 1997-07-16 ID IDP972464A patent/ID19632A/id unknown
- 1997-07-16 AR ARP970103183A patent/AR007898A1/es unknown
- 1997-07-16 AR ARP970103182A patent/AR007897A1/es active IP Right Grant
- 1997-07-16 UY UY24625A patent/UY24625A1/es unknown
- 1997-07-17 JP JP19217397A patent/JP3179050B2/ja not_active Expired - Fee Related
- 1997-07-17 CZ CZ19972274A patent/CZ290898B6/cs not_active IP Right Cessation
- 1997-07-17 CO CO97040541A patent/CO4900064A1/es unknown
- 1997-07-17 MA MA24723A patent/MA24274A1/fr unknown
- 1997-07-18 TR TR97/00659A patent/TR199700659A2/xx unknown
- 1997-07-18 AU AU28756/97A patent/AU719352B2/en not_active Ceased
- 1997-07-18 PL PL97321201A patent/PL321201A1/xx unknown
- 1997-07-18 HR HR97105366.5A patent/HRP970394A2/hr not_active Application Discontinuation
- 1997-07-18 RU RU97113374/04A patent/RU2178412C2/ru not_active IP Right Cessation
- 1997-07-18 CN CN97114707A patent/CN1120154C/zh not_active Expired - Fee Related
- 1997-07-18 NO NO973337A patent/NO308657B1/no unknown
- 1997-07-21 BR BR9704031A patent/BR9704031A/pt not_active IP Right Cessation
- 1997-07-22 KR KR1019970034233A patent/KR100235804B1/ko not_active IP Right Cessation
-
1998
- 1998-08-13 HK HK98109919A patent/HK1009124A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ID19632A (id) | Turunan-turunan 4-hidroksi-piperidina | |
| ID19511A (id) | Turunan-turunan trisiklik tersubstitusi fenilamino | |
| DE69511456D1 (de) | Pfostenanordnung | |
| DE59407422D1 (de) | Gerippestruktur | |
| ID17678A (id) | Turunan-turunan 4-hidroksi-piperidina | |
| DE69402690T2 (de) | Konstruktionsteil | |
| ID17124A (id) | Turunan-turunan karboksilat tersubstitusi | |
| DE59605552D1 (de) | Oberbaukonstruktion | |
| DE9404270U1 (de) | Pfosten | |
| DE9301963U1 (de) | Tragwerk | |
| DE9403223U1 (de) | Zaun | |
| DE29622444U1 (de) | Zaun | |
| KR950027742U (ko) | 건축용 서포트 | |
| ID18086A (id) | Turunan-turunan vinilpiroldinon sefalosporin | |
| KR950009119U (ko) | 건축용 서포트 | |
| DE9318280U1 (de) | Tragwerk | |
| KR960005207U (ko) | 제승기 | |
| KR980000475U (ko) | 싱크대 상판구조 | |
| FI944930A0 (fi) | Konsolirakenne | |
| KR960022901U (ko) | 콘크리트 구조물 | |
| KR960014637U (ko) | 공사장용 철책 | |
| KR950006561U (ko) | 철근 지지구 | |
| DE29603485U1 (de) | Baukörper | |
| ITUD960189A3 (it) | Struttura antisfalcio | |
| ITUD960033V0 (it) | Struttura antisfalcio |